Taking the time to educate patients before their medical device implantation has positive implications for patients, healthcare providers, and medical device manufacturers, according to a new poll.
Taking the time to educate patients before their medical device implantation has positive implications for patients, healthcare providers, and medical device manufacturers, according to a new poll.
Gallup asked patients to rate their level of agreement with 3 statements:
These 3 important aspects of pre-surgery education substantially affected outcomes. Patients who strongly agreed with just 1 statement had higher satisfaction and lower problem incidence. Agreeing with 2 or 3 statements yielded even greater outcomes.
“The vital finding that healthcare providers should heed is that taking the time to educate patients before a procedure has significant consequences for patients, their friends and families, and their community,” wrote Gallup’s Mike Ellrich and Daniela Yu. “But before healthcare leaders take action to improve patient education and communication, they need to know where the biggest gaps exist in these areas.”
Only 37% of respondents who had received a medical implant strongly agreed with all 3 aspects of patient education and 17% agreed with none of them. Less than half of respondents agreed with the statements “I knew what to expect after surgery” and “I was prepared for my experience post-surgery.”
Based on the responses, Gallup determined that patients take care of their part, but that tailored pre-surgery communication with the patient is necessary for successful post-procedure outcomes.
“Though there is room for improving patient education across the board, hospital leaders could enhance patient outcomes by reassessing their education strategy and messages for these key patient segments,” the authors wrote.
Recommendations for how healthcare leaders can improve patient education include:
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More